LumiThera Inc

LumiThera Closes Series C Round of Financing – LumiThera US

SEATTLE, July 8, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has completed its Series C financing. The company raised approximately $14M to support further commercialization of its Valeda Light Delivery System for the treatment for dry …

LumiThera Closes Series C Round of Financing – LumiThera US Read More »

LumiThera Adds Daniel Bertholet to Board of Directors

SEATTLE, Jan. 23, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has added Daniel Bertholet to the Board of Directors.  “We are very excited to have Daniel Bertholet join our Board of Directors,” stated Clark Tedford, Ph.D., President and CEO. …

LumiThera Adds Daniel Bertholet to Board of Directors Read More »